|

Neoadjuvant Chemotherapy (NAC) Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • The University of Texas Health Science Center, Houston2

Indications

  • Cancer2
  • Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Pancreatic Ductal Adenocarcinoma1

Houston, Texas2 trials

EUS-RFA PANCARDINAL-1 Trial

Memorial Hermann Hospital

Phase 2
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

The University of Texas Health Science Center at Houston

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.